# Atovaquone

NDC: 0121-1016
Generic name: Atovaquone
Labeler / Manufacturer: PAI Holdings, LLC dba PAI Pharma
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SUSPENSION
Routes: ORAL
Marketing started: 20240110

FDA application: ANDA214272

## Active ingredients

- ATOVAQUONE: 750 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0121-1016"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0121-1016
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2a7b2c9c-dbdd-41a8-a0eb-e3af4d8212be